Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 5Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2NSCLC 2Brain Neoplasms 2Adenocarcinoma of Lung 2Solid Tumor Cancer 1Non-squamous Non-small Cell Lung Cancer 1Non-small Cell Lung Cancer Metastatic 1Non Squamous Non-small Cell Lung Cancer 1Neoplasms 1Mesothelioma, Malignant 1Meningeal Carcinomatosis 1Melanoma 1Lymphatic Metastasis 1Lung Non-Squamous Non-Small Cell Carcinoma 1Lung Diseases, Interstitial 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease Progression 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma 1Advanced Solid Tumor 1

Interventions

pembrolizumab 1Vinorelbine 1Pemetrexed 1Paclitaxel 1Nivolumab 1Gemcitabine 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lung Diseases, Interstitial × Pemetrexed × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡